SCOPUS 정보 검색 플랫폼

PharmacoEconomics

Volumn 12, Issue 3, 1997, Pages 303-306

The economic potential of tamoxifen prophylaxis in breast cancer

(1) Butler, James R G a

a The Australian National University (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

BREAST CANCER; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; COST CONTROL; ENDOMETRIUM CANCER; FEMALE; HEART INFARCTION; HUMAN; LIFE EXPECTANCY; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOEMBOLISM;

EID: 0030884148 PISSN: 11707690 EISSN: None Source Type: Journal
DOI: 10.2165/00019053-199712030-00002 Document Type: Review

Times cited : (1)

References (16)

1
- 0003193675
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: Part 1
- Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: part 1. Lancet 1992; 339 (8784): 1-15
- (1992) Lancet , vol.339 , Issue.8784 , pp. 1-15

2
- 0026595133
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: Part 2
- Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: part 2. Lancet 1992; 339 (8785): 71-85
- (1992) Lancet , vol.339 , Issue.8785 , pp. 71-85

3
- 0027492907
- Tamoxifen as adjuvant therapy in breast cancer: Current status
- Plowman PN. Tamoxifen as adjuvant therapy in breast cancer: current status. Drugs 1993; 46 (5): 819-33
- (1993) Drugs , vol.46 , Issue.5 , pp. 819-833
- Plowman, P.N.¹

4
- 9844262503
- [unpublished]. Sydney: Centre for Health Economics Research and Evaluation. Westmead Hospital; Discussion paper no.: 25
- Glasziou P, Haas M. An economic evaluation of the use of tamoxifen in the treatment of early breast cancer [unpublished]. Sydney: Centre for Health Economics Research and Evaluation. Westmead Hospital; 1994. Discussion paper no.: 25
- (1994) An Economic Evaluation of the use of Tamoxifen in the Treatment of Early Breast Cancer
- Glasziou, P.¹ Haas, M.²

5
- 0028395371
- Systemic therapy in breast cancer: Efficacy and cost-utility
- Corry JF, Lønning PE. Systemic therapy in breast cancer: efficacy and cost-utility. Pharmacoeconomics 1994; 5 (3): 198-212
- (1994) Pharmacoeconomics , vol.5 , Issue.3 , pp. 198-212
- Corry, J.F.¹ Lønning, P.E.²

6
- 0026728668
- Tamoxifen prophylaxis in breast cancer
- Love RR. Tamoxifen prophylaxis in breast cancer. Oncology 1992; 6 (7): 33-8
- (1992) Oncology , vol.6 , Issue.7 , pp. 33-38
- Love, R.R.¹

7
- 9844225318
- The Love article reviewed
- Meyskens FL, Atiba JO. The Love article reviewed. Oncology 1992; 6 (7): 38-9
- (1992) Oncology , vol.6 , Issue.7 , pp. 38-39
- Meyskens, F.L.¹ Atiba, J.O.²

8
- 9844241296
- The Love article reviewed
- Spicer DV, Henderson BE. The Love article reviewed. Oncology 1992; 6 (7): 40-3
- (1992) Oncology , vol.6 , Issue.7 , pp. 40-43
- Spicer, D.V.¹ Henderson, B.E.²

9
- 0027290493
- Tumoxifen for the primary prevention of breast cancer: A review and critique of the concept and trial
- Bush TL, Helzlsouer KJ. Tumoxifen for the primary prevention of breast cancer: a review and critique of the concept and trial. Epidemiol Rev 1993; 15 (1): 223-43
- (1993) Epidemiol Rev , vol.15 , Issue.1 , pp. 223-243
- Bush, T.L.¹ Helzlsouer, K.J.²

10
- 0027201543
- Tamoxifen: Current issues and future prospective
- Chlebowski RT, Butler J, Nelson A, et al. Tamoxifen: current issues and future prospective. Cancer 1993; 72 (3 Suppl.): 1032-7
- (1993) Cancer , vol.72 , Issue.3 SUPPL. , pp. 1032-1037
- Chlebowski, R.T.¹ Butler, J.² Nelson, A.³

11
- 0029147764
- Base-line quality-of-lite assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial
- Ganz PA, Day R, Ware JE, et al. Base-line quality-of-lite assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. J Natl Cancer Inst 1995; 87 (18): 1372-82
- (1995) J Natl Cancer Inst , vol.87 , Issue.18 , pp. 1372-1382
- Ganz, P.A.¹ Day, R.² Ware, J.E.³

12
- 0025023992
- Prevention of breast cancer with tamoxifen: An update on the Royal Marsden Hospital Pilot Programme
- Powles TJ, Tillyer CR, Jones AL. Prevention of breast cancer with tamoxifen: an update on the Royal Marsden Hospital Pilot Programme. Eur J Cancer 1990; 26 (6): 680-4
- (1990) Eur J Cancer , vol.26 , Issue.6 , pp. 680-684
- Powles, T.J.¹ Tillyer, C.R.² Jones, A.L.³

13
- 0027506733
- Breast cancer chemoprevention
- Costa A. Breast cancer chemoprevention. Eur J Cancer 1993; 29A (4): 589-92
- (1993) Eur J Cancer , vol.29 A , Issue.4 , pp. 589-592
- Costa, A.¹

14
- 0027301840
- Tamoxifen trial in healthy women at risk of breast cancer
- Costa A. Tamoxifen trial in healthy women at risk of breast cancer [letter]. Lancet 1993; 342: 444
- (1993) Lancet , vol.342 , pp. 444
- Costa, A.¹

15
- 0029123403
- The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: An analysis of the tradeoffs
- Nease RF, Ross JM. The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs. Am J Med 1995; 99: 180-89
- (1995) Am J Med , vol.99 , pp. 180-189
- Nease, R.F.¹ Ross, J.M.²

16
- 0025996176
- Symptoms associated with tamoxifen treatment in postmenopausal women
- Love RR, Cameron L, Connell BL, et al. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991; 151 (9): 1842-7
- (1991) Arch Intern Med , vol.151 , Issue.9 , pp. 1842-1847
- Love, R.R.¹ Cameron, L.² Connell, B.L.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.